EMEA (Europe, Middle East and Africa) Dry Powder Inhaler Device Market Report 2018

June 2018 | 113 pages | ID: E1DF222B919EN
QYResearch

Abstracts

In this report, the EMEA Dry Powder Inhaler Device market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Dry Powder Inhaler Device for these regions, from 2013 to 2025 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Dry Powder Inhaler Device market competition by top manufacturers/players, with Dry Powder Inhaler Device sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• GlaxoSmithKline
• AstraZeneca
• Boehringer Ingelheim
• Chiesi
• Cipla
• 3M
• Hovione
• Mannkind
• Meda
• Novartis
• Schering/Merck
• Teva
• Vectura

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Single Dose
• Multi-dose

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Asthma
• COPD
• Other

Contents

EMEA (Europe, Middle East and Africa) Dry Powder Inhaler Device Market Report 2018

1 DRY POWDER INHALER DEVICE OVERVIEW

1.1 Product Overview and Scope of Dry Powder Inhaler Device
1.2 Classification of Dry Powder Inhaler Device
  1.2.1 EMEA Dry Powder Inhaler Device Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 EMEA Dry Powder Inhaler Device Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Single Dose
  1.2.4 Multi-dose
1.3 EMEA Dry Powder Inhaler Device Market by Application/End Users
  1.3.1 EMEA Dry Powder Inhaler Device Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Asthma
  1.3.3 COPD
  1.3.4 Other
1.4 EMEA Dry Powder Inhaler Device Market by Region
  1.4.1 EMEA Dry Powder Inhaler Device Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 Europe Status and Prospect (2013-2025)
  1.4.3 Middle East Status and Prospect (2013-2025)
  1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Dry Powder Inhaler Device (2013-2025)
  1.5.1 EMEA Dry Powder Inhaler Device Sales and Growth Rate (2013-2025)
  1.5.2 EMEA Dry Powder Inhaler Device Revenue and Growth Rate (2013-2025)

2 EMEA DRY POWDER INHALER DEVICE COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Dry Powder Inhaler Device Market Competition by Players/Manufacturers
  2.1.1 EMEA Dry Powder Inhaler Device Sales Volume and Market Share of Major Players (2013-2018)
  2.1.2 EMEA Dry Powder Inhaler Device Revenue and Share by Players (2013-2018)
  2.1.3 EMEA Dry Powder Inhaler Device Sale Price by Players (2013-2018)
2.2 EMEA Dry Powder Inhaler Device (Volume and Value) by Type/Product Category
  2.2.1 EMEA Dry Powder Inhaler Device Sales and Market Share by Type (2013-2018)
  2.2.2 EMEA Dry Powder Inhaler Device Revenue and Market Share by Type (2013-2018)
  2.2.3 EMEA Dry Powder Inhaler Device Sale Price by Type (2013-2018)
2.3 EMEA Dry Powder Inhaler Device (Volume) by Application
2.4 EMEA Dry Powder Inhaler Device (Volume and Value) by Region
  2.4.1 EMEA Dry Powder Inhaler Device Sales and Market Share by Region (2013-2018)
  2.4.2 EMEA Dry Powder Inhaler Device Revenue and Market Share by Region (2013-2018)
  2.4.3 EMEA Dry Powder Inhaler Device Sales Price by Region (2013-2018)

3 EUROPE DRY POWDER INHALER DEVICE (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Dry Powder Inhaler Device Sales and Value (2013-2018)
  3.1.1 Europe Dry Powder Inhaler Device Sales Volume and Growth Rate (2013-2018)
  3.1.2 Europe Dry Powder Inhaler Device Revenue and Growth Rate (2013-2018)
3.2 Europe Dry Powder Inhaler Device Sales and Market Share by Type
3.3 Europe Dry Powder Inhaler Device Sales and Market Share by Application
3.4 Europe Dry Powder Inhaler Device Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Dry Powder Inhaler Device Sales Volume by Countries (2013-2018)
  3.4.2 Europe Dry Powder Inhaler Device Revenue by Countries (2013-2018)
  3.4.3 Germany Dry Powder Inhaler Device Sales and Growth Rate (2013-2018)
  3.4.4 France Dry Powder Inhaler Device Sales and Growth Rate (2013-2018)
  3.4.5 UK Dry Powder Inhaler Device Sales and Growth Rate (2013-2018)
  3.4.6 Russia Dry Powder Inhaler Device Sales and Growth Rate (2013-2018)
  3.4.7 Italy Dry Powder Inhaler Device Sales and Growth Rate (2013-2018)
  3.4.8 Benelux Dry Powder Inhaler Device Sales and Growth Rate (2013-2018)

4 MIDDLE EAST DRY POWDER INHALER DEVICE (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Dry Powder Inhaler Device Sales and Value (2013-2018)
  4.1.1 Middle East Dry Powder Inhaler Device Sales Volume and Growth Rate (2013-2018)
  4.1.2 Middle East Dry Powder Inhaler Device Revenue and Growth Rate (2013-2018)
4.2 Middle East Dry Powder Inhaler Device Sales and Market Share by Type
4.3 Middle East Dry Powder Inhaler Device Sales and Market Share by Application
4.4 Middle East Dry Powder Inhaler Device Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Dry Powder Inhaler Device Sales Volume by Countries (2013-2018)
  4.4.2 Middle East Dry Powder Inhaler Device Revenue by Countries (2013-2018)
  4.4.3 Saudi Arabia Dry Powder Inhaler Device Sales and Growth Rate (2013-2018)
  4.4.4 Israel Dry Powder Inhaler Device Sales and Growth Rate (2013-2018)
  4.4.5 UAE Dry Powder Inhaler Device Sales and Growth Rate (2013-2018)
  4.4.6 Iran Dry Powder Inhaler Device Sales and Growth Rate (2013-2018)

5 AFRICA DRY POWDER INHALER DEVICE (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Dry Powder Inhaler Device Sales and Value (2013-2018)
  5.1.1 Africa Dry Powder Inhaler Device Sales Volume and Growth Rate (2013-2018)
  5.1.2 Africa Dry Powder Inhaler Device Revenue and Growth Rate (2013-2018)
5.2 Africa Dry Powder Inhaler Device Sales and Market Share by Type
5.3 Africa Dry Powder Inhaler Device Sales and Market Share by Application
5.4 Africa Dry Powder Inhaler Device Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Dry Powder Inhaler Device Sales Volume by Countries (2013-2018)
  5.4.2 Africa Dry Powder Inhaler Device Revenue by Countries (2013-2018)
  5.4.3 South Africa Dry Powder Inhaler Device Sales and Growth Rate (2013-2018)
  5.4.4 Nigeria Dry Powder Inhaler Device Sales and Growth Rate (2013-2018)
  5.4.5 Egypt Dry Powder Inhaler Device Sales and Growth Rate (2013-2018)
  5.4.6 Algeria Dry Powder Inhaler Device Sales and Growth Rate (2013-2018)

6 EMEA DRY POWDER INHALER DEVICE MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 GlaxoSmithKline
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Dry Powder Inhaler Device Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 GlaxoSmithKline Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 AstraZeneca
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Dry Powder Inhaler Device Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 AstraZeneca Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Boehringer Ingelheim
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Dry Powder Inhaler Device Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Boehringer Ingelheim Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Chiesi
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Dry Powder Inhaler Device Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Chiesi Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Cipla
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Dry Powder Inhaler Device Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Cipla Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 3M
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Dry Powder Inhaler Device Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 3M Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Hovione
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Dry Powder Inhaler Device Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Hovione Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Mannkind
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Dry Powder Inhaler Device Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Mannkind Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Meda
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Dry Powder Inhaler Device Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Meda Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Novartis
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Dry Powder Inhaler Device Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Novartis Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Schering/Merck
6.12 Teva
6.13 Vectura

7 DRY POWDER INHALER DEVICE MANUFACTURING COST ANALYSIS

7.1 Dry Powder Inhaler Device Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Dry Powder Inhaler Device

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Dry Powder Inhaler Device Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Dry Powder Inhaler Device Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA DRY POWDER INHALER DEVICE MARKET FORECAST (2018-2025)

11.1 EMEA Dry Powder Inhaler Device Sales, Revenue and Price Forecast (2018-2025)
  11.1.1 EMEA Dry Powder Inhaler Device Sales and Growth Rate Forecast (2018-2025)
  11.1.2 EMEA Dry Powder Inhaler Device Revenue and Growth Rate Forecast (2018-2025)
  11.1.3 EMEA Dry Powder Inhaler Device Price and Trend Forecast (2018-2025)
11.2 EMEA Dry Powder Inhaler Device Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Dry Powder Inhaler Device Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Dry Powder Inhaler Device Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Dry Powder Inhaler Device Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Dry Powder Inhaler Device Sales Forecast by Type (2018-2025)
11.7 EMEA Dry Powder Inhaler Device Sales Forecast by Application (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Dry Powder Inhaler Device
Figure EMEA Dry Powder Inhaler Device Sales Volume (K Units) by Type (2013-2025)
Figure EMEA Dry Powder Inhaler Device Sales Volume Market Share by Type (Product Category) in 2017
Figure Single Dose Product Picture
Figure Multi-dose Product Picture
Figure EMEA Dry Powder Inhaler Device Sales Volume (K Units) by Application (2013-2025)
Figure EMEA Sales Market Share of Dry Powder Inhaler Device by Application in 2017
Figure Asthma Examples
Table Key Downstream Customer in Asthma
Figure COPD Examples
Table Key Downstream Customer in COPD
Figure Other Examples
Table Key Downstream Customer in Other
Figure EMEA Dry Powder Inhaler Device Market Size (Million USD) by Region (2013-2025)
Figure Europe Dry Powder Inhaler Device Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Dry Powder Inhaler Device Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Dry Powder Inhaler Device Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Dry Powder Inhaler Device Revenue (Million USD) Status and Forecast by Countries
Figure Africa Dry Powder Inhaler Device Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Dry Powder Inhaler Device Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Dry Powder Inhaler Device Sales Volume and Growth Rate (2013-2025)
Figure EMEA Dry Powder Inhaler Device Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Dry Powder Inhaler Device Market Major Players Product Sales Volume (K Units) (2013-2018)
Table EMEA Dry Powder Inhaler Device Sales Volume (K Units) of Major Players (2013-2018)
Table EMEA Dry Powder Inhaler Device Sales Share by Players (2013-2018)
Figure 2017 Dry Powder Inhaler Device Sales Share by Players
Figure 2017 Dry Powder Inhaler Device Sales Share by Players
Figure EMEA Dry Powder Inhaler Device Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Dry Powder Inhaler Device Revenue (Million USD) by Players (2013-2018)
Table EMEA Dry Powder Inhaler Device Revenue Share by Players (2013-2018)
Table 2017 EMEA Dry Powder Inhaler Device Revenue Share by Players
Table 2017 EMEA Dry Powder Inhaler Device Revenue Share by Players
Table EMEA Dry Powder Inhaler Device Sale Price (USD/Unit) by Players (2013-2018)
Table EMEA Dry Powder Inhaler Device Sales (K Units) and Market Share by Type (2013-2018)
Table EMEA Dry Powder Inhaler Device Sales Share by Type (2013-2018)
Figure Sales Market Share of Dry Powder Inhaler Device by Type (2013-2018)
Figure EMEA Dry Powder Inhaler Device Sales Market Share by Type (2013-2018)
Table EMEA Dry Powder Inhaler Device Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Dry Powder Inhaler Device Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Dry Powder Inhaler Device by Type in 2017
Table EMEA Dry Powder Inhaler Device Sale Price (USD/Unit) by Type (2013-2018)
Table EMEA Dry Powder Inhaler Device Sales (K Units) and Market Share by Application (2013-2018)
Table EMEA Dry Powder Inhaler Device Sales Share by Application (2013-2018)
Figure Sales Market Share of Dry Powder Inhaler Device by Application (2013-2018)
Figure EMEA Dry Powder Inhaler Device Sales Market Share by Application in 2017
Table EMEA Dry Powder Inhaler Device Sales (K Units) and Market Share by Region (2013-2018)
Table EMEA Dry Powder Inhaler Device Sales Share by Region (2013-2018)
Figure Sales Market Share of Dry Powder Inhaler Device by Region (2013-2018)
Figure EMEA Dry Powder Inhaler Device Sales Market Share in 2017
Table EMEA Dry Powder Inhaler Device Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Dry Powder Inhaler Device Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Dry Powder Inhaler Device by Region (2013-2018)
Figure EMEA Dry Powder Inhaler Device Revenue Market Share Regions in 2017
Table EMEA Dry Powder Inhaler Device Sales Price (USD/Unit) by Region (2013-2018)
Figure Europe Dry Powder Inhaler Device Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Dry Powder Inhaler Device Revenue and Growth Rate (2013-2018)
Table Europe Dry Powder Inhaler Device Sales (K Units) by Type (2013-2018)
Table Europe Dry Powder Inhaler Device Market Share by Type (2013-2018)
Figure Europe Dry Powder Inhaler Device Market Share by Type in 2017
Table Europe Dry Powder Inhaler Device Sales (K Units) by Application (2013-2018)
Table Europe Dry Powder Inhaler Device Market Share by Application (2013-2018)
Figure Europe Dry Powder Inhaler Device Market Share by Application in 2017
Table Europe Dry Powder Inhaler Device Sales (K Units) by Countries (2013-2018)
Table Europe Dry Powder Inhaler Device Sales Market Share by Countries (2013-2018)
Figure Europe Dry Powder Inhaler Device Sales Market Share by Countries (2013-2018)
Figure Europe Dry Powder Inhaler Device Sales Market Share by Countries in 2017
Table Europe Dry Powder Inhaler Device Revenue (Million USD) by Countries (2013-2018)
Table Europe Dry Powder Inhaler Device Revenue Market Share by Countries (2013-2018)
Figure Europe Dry Powder Inhaler Device Revenue Market Share by Countries (2013-2018)
Figure Europe Dry Powder Inhaler Device Revenue Market Share by Countries in 2017
Figure Germany Dry Powder Inhaler Device Sales (K Units) and Growth Rate (2013-2018)
Figure France Dry Powder Inhaler Device Sales (K Units) and Growth Rate (2013-2018)
Figure UK Dry Powder Inhaler Device Sales (K Units) and Growth Rate (2013-2018)
Figure Russia Dry Powder Inhaler Device Sales (K Units) and Growth Rate (2013-2018)
Figure Italy Dry Powder Inhaler Device Sales (K Units) and Growth Rate (2013-2018)
Figure Benelux Dry Powder Inhaler Device Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Dry Powder Inhaler Device Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Dry Powder Inhaler Device Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Dry Powder Inhaler Device Sales (K Units) by Type (2013-2018)
Table Middle East Dry Powder Inhaler Device Market Share by Type (2013-2018)
Figure Middle East Dry Powder Inhaler Device Market Share by Type (2013-2018)
Table Middle East Dry Powder Inhaler Device Sales (K Units) by Applications (2013-2018)
Table Middle East Dry Powder Inhaler Device Market Share by Applications (2013-2018)
Figure Middle East Dry Powder Inhaler Device Sales Market Share by Application in 2017
Table Middle East Dry Powder Inhaler Device Sales Volume (K Units) by Countries (2013-2018)
Table Middle East Dry Powder Inhaler Device Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Dry Powder Inhaler Device Sales Volume Market Share by Countries in 2017
Table Middle East Dry Powder Inhaler Device Revenue (Million USD) by Countries (2013-2018)
Table Middle East Dry Powder Inhaler Device Revenue Market Share by Countries (2013-2018)
Figure Middle East Dry Powder Inhaler Device Revenue Market Share by Countries (2013-2018)
Figure Middle East Dry Powder Inhaler Device Revenue Market Share by Countries in 2017
Figure Saudi Arabia Dry Powder Inhaler Device Sales (K Units) and Growth Rate (2013-2018)
Figure Israel Dry Powder Inhaler Device Sales (K Units) and Growth Rate (2013-2018)
Figure UAE Dry Powder Inhaler Device Sales (K Units) and Growth Rate (2013-2018)
Figure Iran Dry Powder Inhaler Device Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Dry Powder Inhaler Device Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Dry Powder Inhaler Device Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Dry Powder Inhaler Device Sales (K Units) by Type (2013-2018)
Table Africa Dry Powder Inhaler Device Sales Market Share by Type (2013-2018)
Figure Africa Dry Powder Inhaler Device Sales Market Share by Type (2013-2018)
Figure Africa Dry Powder Inhaler Device Sales Market Share by Type in 2017
Table Africa Dry Powder Inhaler Device Sales (K Units) by Application (2013-2018)
Table Africa Dry Powder Inhaler Device Sales Market Share by Application (2013-2018)
Figure Africa Dry Powder Inhaler Device Sales Market Share by Application (2013-2018)
Table Africa Dry Powder Inhaler Device Sales Volume (K Units) by Countries (2013-2018)
Table Africa Dry Powder Inhaler Device Sales Market Share by Countries (2013-2018)
Figure Africa Dry Powder Inhaler Device Sales Market Share by Countries (2013-2018)
Figure Africa Dry Powder Inhaler Device Sales Market Share by Countries in 2017
Table Africa Dry Powder Inhaler Device Revenue (Million USD) by Countries (2013-2018)
Table Africa Dry Powder Inhaler Device Revenue Market Share by Countries (2013-2018)
Figure Africa Dry Powder Inhaler Device Revenue Market Share by Countries (2013-2018)
Figure Africa Dry Powder Inhaler Device Revenue Market Share by Countries in 2017
Figure South Africa Dry Powder Inhaler Device Sales (K Units) and Growth Rate (2013-2018)
Figure Nigeria Dry Powder Inhaler Device Sales (K Units) and Growth Rate (2013-2018)
Figure Egypt Dry Powder Inhaler Device Sales (K Units) and Growth Rate (2013-2018)
Figure Algeria Dry Powder Inhaler Device Sales (K Units) and Growth Rate (2013-2018)
Table GlaxoSmithKline Dry Powder Inhaler Device Basic Information List
Table GlaxoSmithKline Dry Powder Inhaler Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GlaxoSmithKline Dry Powder Inhaler Device Sales (K Units) and Growth Rate (2013-2018)
Figure GlaxoSmithKline Dry Powder Inhaler Device Sales Market Share in EMEA (2013-2018)
Figure GlaxoSmithKline Dry Powder Inhaler Device Revenue Market Share in EMEA (2013-2018)
Table AstraZeneca Dry Powder Inhaler Device Basic Information List
Table AstraZeneca Dry Powder Inhaler Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AstraZeneca Dry Powder Inhaler Device Sales (K Units) and Growth Rate (2013-2018)
Figure AstraZeneca Dry Powder Inhaler Device Sales Market Share in EMEA (2013-2018)
Figure AstraZeneca Dry Powder Inhaler Device Revenue Market Share in EMEA (2013-2018)
Table Boehringer Ingelheim Dry Powder Inhaler Device Basic Information List
Table Boehringer Ingelheim Dry Powder Inhaler Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Boehringer Ingelheim Dry Powder Inhaler Device Sales (K Units) and Growth Rate (2013-2018)
Figure Boehringer Ingelheim Dry Powder Inhaler Device Sales Market Share in EMEA (2013-2018)
Figure Boehringer Ingelheim Dry Powder Inhaler Device Revenue Market Share in EMEA (2013-2018)
Table Chiesi Dry Powder Inhaler Device Basic Information List
Table Chiesi Dry Powder Inhaler Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Chiesi Dry Powder Inhaler Device Sales (K Units) and Growth Rate (2013-2018)
Figure Chiesi Dry Powder Inhaler Device Sales Market Share in EMEA (2013-2018)
Figure Chiesi Dry Powder Inhaler Device Revenue Market Share in EMEA (2013-2018)
Table Cipla Dry Powder Inhaler Device Basic Information List
Table Cipla Dry Powder Inhaler Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Cipla Dry Powder Inhaler Device Sales (K Units) and Growth Rate (2013-2018)
Figure Cipla Dry Powder Inhaler Device Sales Market Share in EMEA (2013-2018)
Figure Cipla Dry Powder Inhaler Device Revenue Market Share in EMEA (2013-2018)
Table 3M Dry Powder Inhaler Device Basic Information List
Table 3M Dry Powder Inhaler Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure 3M Dry Powder Inhaler Device Sales (K Units) and Growth Rate (2013-2018)
Figure 3M Dry Powder Inhaler Device Sales Market Share in EMEA (2013-2018)
Figure 3M Dry Powder Inhaler Device Revenue Market Share in EMEA (2013-2018)
Table Hovione Dry Powder Inhaler Device Basic Information List
Table Hovione Dry Powder Inhaler Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Hovione Dry Powder Inhaler Device Sales (K Units) and Growth Rate (2013-2018)
Figure Hovione Dry Powder Inhaler Device Sales Market Share in EMEA (2013-2018)
Figure Hovione Dry Powder Inhaler Device Revenue Market Share in EMEA (2013-2018)
Table Mannkind Dry Powder Inhaler Device Basic Information List
Table Mannkind Dry Powder Inhaler Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Mannkind Dry Powder Inhaler Device Sales (K Units) and Growth Rate (2013-2018)
Figure Mannkind Dry Powder Inhaler Device Sales Market Share in EMEA (2013-2018)
Figure Mannkind Dry Powder Inhaler Device Revenue Market Share in EMEA (2013-2018)
Table Meda Dry Powder Inhaler Device Basic Information List
Table Meda Dry Powder Inhaler Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Meda Dry Powder Inhaler Device Sales (K Units) and Growth Rate (2013-2018)
Figure Meda Dry Powder Inhaler Device Sales Market Share in EMEA (2013-2018)
Figure Meda Dry Powder Inhaler Device Revenue Market Share in EMEA (2013-2018)
Table Novartis Dry Powder Inhaler Device Basic Information List
Table Novartis Dry Powder Inhaler Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Dry Powder Inhaler Device Sales (K Units) and Growth Rate (2013-2018)
Figure Novartis Dry Powder Inhaler Device Sales Market Share in EMEA (2013-2018)
Figure Novartis Dry Powder Inhaler Device Revenue Market Share in EMEA (2013-2018)
Table Schering/Merck Dry Powder Inhaler Device Basic Information List
Table Teva Dry Powder Inhaler Device Basic Information List
Table Vectura Dry Powder Inhaler Device Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Dry Powder Inhaler Device
Figure Manufacturing Process Analysis of Dry Powder Inhaler Device
Figure Dry Powder Inhaler Device Industrial Chain Analysis
Table Raw Materials Sources of Dry Powder Inhaler Device Major Manufacturers in 2017
Table Major Buyers of Dry Powder Inhaler Device
Table Distributors/Traders List
Figure EMEA Dry Powder Inhaler Device Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure EMEA Dry Powder Inhaler Device Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Dry Powder Inhaler Device Price (USD/Unit) and Trend Forecast (2018-2025)
Table EMEA Dry Powder Inhaler Device Sales (K Units) Forecast by Region (2018-2025)
Figure EMEA Dry Powder Inhaler Device Sales Market Share Forecast by Region (2018-2025)
Table EMEA Dry Powder Inhaler Device Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Dry Powder Inhaler Device Revenue Market Share Forecast by Region (2018-2025)
Table Europe Dry Powder Inhaler Device Sales (K Units) Forecast by Countries (2018-2025)
Figure Europe Dry Powder Inhaler Device Sales Market Share Forecast by Countries (2018-2025)
Table Europe Dry Powder Inhaler Device Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Dry Powder Inhaler Device Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Dry Powder Inhaler Device Sales (K Units) Forecast by Countries (2018-2025)
Figure Middle East Dry Powder Inhaler Device Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Dry Powder Inhaler Device Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Dry Powder Inhaler Device Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Dry Powder Inhaler Device Sales (K Units) Forecast by Countries (2018-2025)
Figure Africa Dry Powder Inhaler Device Sales Market Share Forecast by Countries (2018-2025)
Table Africa Dry Powder Inhaler Device Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Dry Powder Inhaler Device Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Dry Powder Inhaler Device Sales (K Units) Forecast by Type (2018-2025)
Figure EMEA Dry Powder Inhaler Device Sales Market Share Forecast by Type (2018-2025)
Table EMEA Dry Powder Inhaler Device Sales (K Units) Forecast by Application (2018-2025)
Figure EMEA Dry Powder Inhaler Device Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources